Jinfiniti Precision Medicine Founder Jin Xiong She talks about NAD optimization

“Biomarkers of Human Longevity: State of the Market and Diversity of Practical Applications Q4 2021” was a 2-day conference featuring talks and panel discussions among industry leaders, companies, investors and practitioners in the rapidly growing domain of Biomarkers of Human Longevity.

Jinfiniti Precision Medicine founder Jin Xiong She discusses NAD optimization. 


This field is for validation purposes and should be left unchanged.
Already have an account? Log in here